Preclinical and translational vaccine development for HIV and other candidate agents

Award Notice Posted

Solicitation number
75N93019R00023
Agency
Awarded
to Sri International
Set-aside
Partial Small Business

Opportunity facts

Contract number
75N93022D00007 Federal IDV award
Place of performance
Menlo Park, California 94025, United States

Notice details come from SAM.gov. Updated .

About this opportunity

This Award Notice announces a contract awarded by the National Institute of Allergy and Infectious Diseases to SRI International for preclinical and translational vaccine development for HIV and other candidate agents. The indefinite-delivery/indefinite-quantity contract has a maximum value of $364,553,934 and a period of performance from December 1, 2021 through November 30, 2028 to support preclinical and translational vaccine development for HIV and other candidate agents under solicitation number 75N93019R00023, with work to be performed by SRI International in Menlo Park, California.

Notice text

PRECLINICAL AND TRANSLATIONAL VACCINE DEVELOPMENT FOR HIV AND OTHER CANDIDATE AGENTS

Awarded contract 75N93022D00007 to SRI International for 364553934.00 on 2021-12-01.

Files

File Type Posted
Award Synopsis SRI.pdf PDF

Notice history

6 of 8 notices listed here. See the rest on GovTribe.

Similar open opportunities

Opportunity Agency Set-aside Responses due
Pre-Clinical Models of Infectious Diseases United States · NAICS 541714 National Institute of Allergy and Infectious Diseases No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors